Complex Regional Pain Syndrome (CRPS) is a chronic condition that causes intense pain, often in the lower body (such as the foot, ankle, knee, leg, or hip). CRPS typically develops after an injury or surgery – however, the pain associated with CRPS is usually much greater than the original injury.
Symptoms of CRPS include:
If you’re living with CRPS pain, you may be a candidate for DRG therapy – a new, non-drug approach to pain relief currently being offered at select pain treatment centers through the TARGET Clinical Study.
Neurostimulaton is a non-drug option for treating chronic pain that uses a small implanted device called a “neurostimulator.” The neurostimulator delivers mild electrical pulses to the nerves in your spinal cord – replacing the original pain signal with a tingling or massaging feeling, covering the specific area where you feel pain. FDA-approved neurostimulators have been used to treat over 300,000 chronic pain sufferers.
One benefit of DRG therapy is that you can try it for a period of time (typically 3 - 12 days) before you have it implanted. The temporary DRG system is placed through a short, outpatient procedure and is completely reversible. Your doctor will place thin wires, called leads, in your back. The leads connect to a temporary device you can wear outside of your clothing. If after the trial period you are satisfied with your pain relief, you can choose to have the system implanted. This is done through another short, reversible surgical procedure to place the neurostimulator beneath the skin.
If you’re living with CRPS pain affecting the lower body (such as the foot, ankle, knee, leg, or hip), you may be a candidate for DRG therapy – a new, non-drug approach to pain relief currently being offered at select pain treatment centers through the TARGET Clinical Study. DRG therapy is FDA-approved for the treatment of CRPS pain affecting the lower limbs, and this study will help gather additional information about this new therapy.
As a participant in the TARGET Study, you will be asked to visit your local study center 4 times over a 12-month period after receiving your DRG system. During these visits, your study doctor will ask about how you are feeling, check your DRG system, and have you complete a few questionnaires to document your experiences. You may also be reimbursed for your time and travel to attend these visits.
* Levy, R. & Deer, T. (2015). A prospective, randomized, multi-center controlled clinical trial to assess the safety and efficacy of the Spinal Modulation Axium Neurostimulator System in the treatment of chronic pain. Presented at NANS 2015.
See If You Qualify
To see if you might qualify for the TARGET Study, and to get connected with the study center in your area to learn more, please complete the questionnaire below.